MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, EVFM has $13,807K in assets. $83,976K in debts.

Balance Sheets Overview

Current Ratio
10.13%
Quick Ratio
7.97%
Debt to Asset Ratio
608.21%
Assets Breakdown
    • Intangible asset, net (note 7)
    • Trade accounts receivable, net
    • Inventories
    • Others
Liabilities Breakdown
    • Accumulated deficit
    • Additional paid-in capital
    • Convertible notes-Adjuvant Notes
    • Others

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Balance Sheets
2025-09-30
2025-06-30
Restricted cash
840 748
Cash and cash equivalents
-0
Trade accounts receivable, net
4,435 4,934
Inventories
1,684 1,906
Prepaid and other current assets
959 1,382
Total current assets
7,918 8,970
Property and equipment, gross
532 -
Less accumulated depreciation
112 -
Property and equipment, net
420 424
Operating lease right-of-use assets
195 214
Intangible asset, net (note 7)
5,238 4,738
Other noncurrent assets
36 36
Total assets
13,807 14,382
Accounts payable
11,624 12,291
Convertible notes-Baker Bros Notes
18,509 14,746
Convertible notes-Related Party
983 35
Convertible notes-Adjuvant Notes
32,167 31,933
Short term debt
291 383
Accrued expenses
1,363 3,327
Accrued compensation
3,609 3,249
Operating lease liabilities current
124 124
Derivative liabilities
1,140 3
Contingent liabilities - current (note 7)
215 213
Other current liabilities
8,161 7,589
Total current liabilities
78,186 73,893
Operating lease liabilities - noncurrent
72 89
Contingent liabilities - noncurrent (note 7)
5,718 5,230
Total liabilities
83,976 79,212
Convertible and redeemable preferred stock
4,897 4,786
Common stock, 0.0001 par value 3,000,000,000 shares authorized 123,956,354 and 113,356,354 shares issued and outstanding at september 30, 2025 and december 31, 2024, respectively
12 12
Additional paid-in capital
831,816 831,424
Accumulated other comprehensive loss
-6,718 -2,556
Accumulated deficit
-900,176 -898,496
Total stockholders deficit
-75,066 -69,616
Total liabilities, convertible and redeemable preferred stock and stockholders deficit
13,807 14,382
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Property and equipment,gross$532K Prepaid and othercurrent assets$959K Inventories$1,684K Trade accountsreceivable, net$4,435K Restricted cash$840K Other noncurrentassets$36K Intangible asset, net (note7)$5,238K Operating leaseright-of-use assets$195K Property and equipment,net$420K Total current assets$7,918K Less accumulateddepreciation$112K Total assets$13,807K Accumulated deficit-$900,176K Accumulated othercomprehensive loss-$6,718K Total liabilities,convertible and redeemable...$13,807K Total stockholdersdeficit-$75,066K Additional paid-in capital$831,816K Common stock, 0.0001par value...$12K Convertible and redeemablepreferred stock$4,897K Total liabilities$83,976K Contingent liabilities -noncurrent (note 7)$5,718K Operating leaseliabilities - noncurrent$72K Total currentliabilities$78,186K Other currentliabilities$8,161K Contingent liabilities -current (note 7)$215K Derivative liabilities$1,140K Operating leaseliabilities current$124K Accrued compensation$3,609K Accrued expenses$1,363K Short term debt$291K Convertible notes-AdjuvantNotes$32,167K Convertible notes-RelatedParty$983K Convertible notes-BakerBros Notes$18,509K Accounts payable$11,624K

Evofem Biosciences, Inc. (EVFM)

Evofem Biosciences, Inc. (EVFM)